Detalhe da pesquisa
1.
The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis.
Nat Immunol
; 20(8): 1012-1022, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263276
2.
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.
Immunity
; 52(5): 856-871.e8, 2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32289253
3.
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer.
Br J Cancer
; 128(2): 331-341, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385556
4.
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.
Blood
; 119(2): 411-21, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22067385
5.
Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages.
J Immunol
; 188(8): 4081-92, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22442441
6.
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study.
Infect Dis Ther
; 12(10): 2437-2456, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798468
7.
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia.
Infect Dis Ther
; 11(4): 1559-1574, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618953
8.
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19.
EClinicalMedicine
; 48: 101450, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582123
9.
Differential regulation of iron homeostasis during human macrophage polarized activation.
Eur J Immunol
; 40(3): 824-35, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20039303
10.
Multiple anti-tumor effects of Reparixin on thyroid cancer.
Oncotarget
; 8(22): 35946-35961, 2017 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28415590
11.
Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
Oncotarget
; 8(9): 14428-14442, 2017 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129639
12.
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
Clin Cancer Res
; 22(15): 3924-36, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26957562
13.
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling.
Oncotarget
; 6(41): 43375-94, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26517518
14.
A glimpse on the phenomenon of macrophage polarization during atherosclerosis.
Immunobiology
; 216(11): 1172-6, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21802768
15.
Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.
J Neuroimmunol
; 230(1-2): 74-84, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20926142